| Financial Year |
March 31 2023 |
| Monetary Funds |
863,701,058.02 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
16,102,635.79 |
| Accounts Receivable |
1,026,260,606.95 |
| Advances to Suppliers |
62,495,189.81 |
| Other Receivables |
10,941,914.92 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
969,460,174.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
31,518,959.71 |
| Total Current Assets |
3,136,311,401.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
57,232,517.60 |
| Investment Properties |
47,210,001.26 |
| Fixed Assetes |
3,368,452,767.55 |
| Under-construction Projects |
621,427,525.46 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
467,720,602.99 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,896,124.63 |
| Deferred Income Tax Assets |
28,110,217.67 |
| Other Non-Current Assets |
44,274,675.53 |
| Sub-Total of Non-Current Assets |
4,840,338,514.08 |
| Total Assets |
7,976,649,915.84 |
| Short-Term Loans |
233,127,580.96 |
| Trading Financial liabilities |
-- |
| Notes Payable |
523,539,266.83 |
| Accounts Payable |
562,696,695.01 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
108,230,824.02 |
| Taxes Payable |
54,589,332.88 |
| Interest Payable |
-- |
| Dividend Payable |
5,310,599.53 |
| Other payables |
490,347,496.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
54,795,430.95 |
| Other Current Liabilities |
20,424,891.69 |
| Sub-Total of Current Liabilities |
2,136,889,989.35 |
| Long-term Loans |
1,047,370,534.19 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
20,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
104,383,682.06 |
| Other Non-Current Liabilities |
3,561,500.00 |
| Sub-Total of Non-Current Liabilities |
1,290,127,600.21 |
| Total Liabilities |
3,427,017,589.56 |
| Paid-In Capital(Or Share Stock) |
673,887,535.00 |
| Capital Surplus |
1,030,826,413.61 |
| Surplus Reserve |
356,955,596.10 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,139,658,147.75 |
| Minority Stockholder's Interest |
225,670,394.50 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,323,961,931.78 |
| Owner's Equity（Stockholder's Equity） |
4,549,632,326.28 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,976,649,915.84 |
